Industry News

'Mulmin vitamin drops' is a combination of synthetic vitamins and minerals meant for children of one year age. However, the Food Safety and Standards Authority of India (FSSAI) issued a notice to the company to stop manufacture, sale, distribution and import of Mulmin drops and recall the existing products from the market with immediate effect.

(NewsVoir); UCB, a multinational biopharmaceutical company, and Genpact (NYSE: G), a global leader in designing, transforming, and running intelligent business operations, have received the Aecus Innovation Award in recognition of their close collaboration in driving transformation that achieved far-reaching operational efficiencies in UCB’s global business services (GBS) finance organization.

A new study conducted at Saint Louis University has found a way to stop cancer cell growth. The study appeared in Cancer Cell.

"Cancer cells look for metabolic pathways to find the parts to grow and divide. If they don't have the parts, they just die," said Thomas Burris, chair of pharmacology and physiology at Saint Louis University, US.

Ricoh India, a wholly-owned subsidiary of Japanese imaging and electronics major Ricoh, launched  a new medical imaging solution called ‘Picasso’ (Patient is Central to this Advanced Solution and Service Offering) recently in Hyderabad. Picaso is web-based multi-specialty cloud-enabled imaging solution. The new innovative medical imaging solution is designed to offer benefits to patients, radiologists, consultants and hospitals and drastic reduction in the healthcare costs for the patients.

Jubilant Life Sciences has announced that it had received approval of the US Food and Drug Administration (FDA) for its tablets used in treating adults for various infections, including pneumonia. The market size for Levofloxacin is estimated to be $28 million (Rs.179 crore) per annum.

TAKE Solutions Ltd., a global business technology solutions provider, was awarded a patent by the United States Patent and Trademark Office (USPTO) for its "Method for Optimizing Clinical Data Standardization". It provides cost-effective and comprehensive solutions for enterprises across diverse sectors including pharmaceuticals, high technology, consumer packaged goods. TAKE’s global headquarters is in Chennai, India; its US headquarters is located in Princeton, New Jersey. This process leverages TAKE Solutions’ clinical accelerators to reduce the time taken to standardize trial data by over 50% (when compared to standardization without the accelerators), thus reducing time to market.

[adsense:336x280:8701650588]

Maruishi Pharmaceutical Co., Ltd.  & Daiichi Sankyo Company, Limited, a global pharmaceutical company Collaborate to commercialize the general anaesthesia analgesic, remifentanil injection generic. Maruishi Pharmaceutical is currently applying for a manufacture and marketing license. Once Maruishi Pharmaceutical has acquired a license for the manufacturing and marketing of this drug, the plan is for Maruishi Pharmaceutical to handle its manufacture and Daiichi Sankyo to handle its marketing, while both companies will jointly conduct promotion activities.

Zydus Cadila, a global pharmaceutical company, has received the final approval from the US Food and Drug Administration (FDA) to market pyridostigmine bromide tablets USP, 60 mg.  It is used for treating various neurological disorders.